Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas

Molecular Carcinogenesis

Volumn 8, Issue 4, 1993, Pages 306-311

  Esteve, Asuncion ^a   Montesano, Ruggero ^a   Hollstein, Monica ^a   Lehman, Theresa ^b   Harris, Curtis C ^b   Jiang, Wei ^c   Weinstein, I Bernard ^c   Ruol, Alberto ^d   Peracchia, Alberto ^d  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Columbia University ^*  (United States)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

gene amplification; oncogene; Tumor suppressor genes

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; ESOPHAGUS CARCINOMA; GENE AMPLIFICATION; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, MYC; GENES, P53; GENES, RETINOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; NEOPLASM PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0027771838     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.2940080414     Document Type: Article

References (36)

1. Estimates of the worldwide frequency of sixteen major cancers in 1980
2. The molecular genetics of cancer
3. Human breast cancer: Correlation of relapse and survival with amplification of the HER‐2/neu oncogene
4. A genetic model for colorectal tumori‐genesis
5. Rapid detection of ras oncogenes in human tumors: Applications to colon, esophageal, and gastric cancer
6. Amplification of the EGF receptor and c‐myc genes in human esophageal cancers
7. No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high‐incidence area for esophageal and gastric cancers
8. Genetic analysis of human esophageal tumors from two high incidence geographic areas: Frequent p53 substitutions and absence of ras mutations
9. High incidence of EGF receptor hyperproduction in esophageal squamous‐cell carcinomas
10. p53 mutations in human cancers
11. Frequent mutation of the p53 gene in human esophageal cancer
12. p53 gene mutations in Barrett's epithelium and esophageal cancer
13. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer
14. p53 mutations in gastric and esophageal cancers
15. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas
16. The retinoblastoma gene and gene product
17. Abrogation by c‐myc of G1 phase arrest induced by RB protein but not by p53
18. ras‐induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation
19. Amplification of a gene encoding a p53‐associated protein in human sarcomas
20. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53‐mediated transactivation
21. Expression of human p53 in bacteria: Application to the analysis of p53 expression in human tumors
22. PCR detection of a neutral CGA/CGG dimorphism in exon 6 of the human p53 gene
23. Mutations in the p53 gene occur in diverse human tumour types
24. Structural aspects of the p53 protein in relation to gene evolution
25. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies
26. p53 function and dysfunction
27. Wild‐type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication
28. The acidic transcriptional activating domain of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV‐1 DNA replication
29. Altered cell cycle arrest and gene amplification potential accompany loss of wild‐type p53
30. Wild‐type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
31. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
32. Expression from the murine p53 promoter is mediated by factor binding to a downstream helix‐loop‐helix recognition motif
33. Functional interaction of p53 with HPV18 E6, c‐myc, and H‐ras in 3T3 cells
34. The p53 tumour suppressor gene and product
35. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins